Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation by Kwak, Hyeong-Il et al.
ORIGINAL PAPER
Calpain-mediated vimentin cleavage occurs upstream of MT1-
MMP membrane translocation to facilitate endothelial sprout
initiation
Hyeong-Il Kwak • Hojin Kang • Jui M. Dave •
E. Adriana Mendoza • Shih-Chi Su •
Steve A. Maxwell • Kayla J. Bayless
Received: 15 October 2011/Accepted: 20 February 2012/Published online: 11 March 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Endothelial cells normally line the vasculature
and remain quiescent. However, these cells can be rapidly
stimulated to undergo morphogenesis and initiate new
blood vessel formation given the proper cues. This study
reports a new mechanism for initiating angiogenic sprout
formation that involves vimentin, the major intermediate
ﬁlament protein in endothelial cells. Initial studies con-
ﬁrmed vimentin was required for sphingosine 1-phosphate
(S1P)- and growth factor (GF)-induced endothelial cell
invasion, and vimentin was cleaved by calpains during
invasion. Calpains were predominantly activated by GF
and were required for sprout initiation. Because others have
reported membrane type 1-matrix metalloproteinase (MT1-
MMP) is required for endothelial sprouting responses, we
tested whether vimentin and calpain acted upstream of
MT1-MMP. Both calpain and vimentin were required for
successful MT1-MMP membrane translocation, which was
stimulated by S1P. In addition, vimentin complexed with
MT1-MMP in a manner that required both the cytoplasmic
domain of MT1-MMP and calpain activation, which
increased the soluble pool of vimentin in endothelial cells.
Altogether, these data indicate that pro-angiogenic signals
converge to activate calpain-dependent vimentin cleavage
and increase vimentin solubility, which act upstream to
facilitate MT1-MMP membrane translocation, resulting in
successful endothelial sprout formation in three-dimen-
sional collagen matrices. These ﬁndings help explain why
S1P and GF synergize to stimulate robust sprouting in 3D
collagen matrices.
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Introduction
Angiogenesis is the formation of new blood vessels from
pre-existing structures and is a key step in development,
wound healing and pathological events [1, 2]. While the
endothelium is normally quiescent and exhibits infrequent
turnover, endothelial cells (ECs) that line the vascular
system must respond rapidly to external cues to initiate
angiogenesis and extend new sprouts into the surrounding
extracellular matrix. Exogenous extracellular pro-angio-
genic factors such as vascular endothelial growth factor
(VEGF), basic ﬁbroblast growth factor (bFGF) and sphin-
gosine 1-phosphate (S1P), potently stimulate new blood
vessel growth [3–5]. Thus, in response to various pro-
angiogenic cues, ECs initiate the formation of new vascular
networks. However, the molecular mechanisms that medi-
ate angiogenic sprouting are not completely understood.
Here, we investigate the intermediate ﬁlament protein
vimentin as a regulator of angiogenic sprouting. Interme-
diate ﬁlament proteins were initially thought to function
solely for mechanical stabilization of cells but are more
recently being recognized as regulators of signal trans-
duction [6]. Endothelial cells express the intermediate ﬁl-
ament vimentin [7], and although no overt phenotypic
alterations were observed in the original report of vimentin
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DOI 10.1007/s10456-012-9262-4null animals [8], subsequent studies revealed defects in
endothelial barrier function [9]. The lack of an overt phe-
notype in vimentin null animals [8], combined with a
multitude of evidence that vimentin is involved in signal
transduction in isolated cell systems [6] has created a
conundrum in the ﬁeld with respect to the function of
vimentin [7]. Eckes et al. [10] reported that vimentin null
mice exhibit a lag in granulation tissue formation, a process
that involves extensive angiogenic sprouting. Further,
vimentin null mice have reduced corneal neovasculariza-
tion [10] and hypoxia-induced retinal neovascularization
responses [11]. Although these anecdotal examples suggest
intermediate ﬁlaments are necessary for angiogenic
responses, the underlying mechanism remains unclear and
further investigation is warranted.
Calpains are intracellular calcium-activated cysteine
proteases and are viable candidates for controlling the
transition from adherent to invasive ECs. Calpains regulate
cell migration on two-dimensional substrates by cleavage
of the actin regulatory proteins talin, vinculin, paxillin,
focal adhesion kinase and cortactin [12–14]. Calpains are
required for membrane protrusion, focal contact dissolu-
tion, cell membrane release during cell spreading, and in-
vadopodia formation [13, 15–17]. Calpains can also cleave
the N-terminus of the intermediate ﬁlament protein,
vimentin [18, 19], rendering vimentin incapable of forming
insoluble, polymerized intermediate ﬁlaments [20].
Pro-angiogenic factors, including VEGF, activate calpains
[21–23], and calpain inhibitors block angiogenesis in vivo
[22, 24, 25]. These studies provide a supportive platform to
investigate a functional requirement for calpains in initi-
ating angiogenic sprouting events and determine potential
downstream intracellular signals that result from calpain
activation.
Membrane-type matrix metalloproteinases (MT-MMPs)
coordinate with growth factors (GF) and integrins to direct
angiogenic sprouting and lumen formation [26–31]. While
MT1-MMP is required for vessel outgrowth and lumen
formation, the precise intracellular molecular events that
control MT1-MMP activation and membrane translocation
following stimulation with pro-angiogenic factors are not
completely deﬁned. In this study, we uncover a new
pathway where calpain cleavage of vimentin facilitates
MT1-MMP membrane localization to initiate angiogenesis
in primary ECs. Calpain activation and increased vimentin
solubility are key molecular events that support pro-
angiogenic factor-stimulated MT1-MMP-dependent
sprouting. This study is the ﬁrst to demonstrate an endo-
thelial-speciﬁc requirement for the intermediate ﬁlament,
vimentin, in directing angiogenic events. Our data provide
new information about the molecular signals responsible
for endothelial cell sprouting and have implications for a
general role of this pathway in regulating cell invasion.
Materials and methods
Reagents
Human umbilical vein ECs (Lonza) were maintained as
previously described [32] and used at passages 3–6 for all
invasion and wound healing studies. Calpain inhibitor III
(Z-Val-Phe-H; MDL 28170) was purchased from EMD
Biosciences. All other reagents were from Sigma-Aldrich
unless indicated.
Expression vector construction
Human MT1-MMP was ampliﬁed from human umbilical
vein endothelial cell cDNA generated in the laboratory [33]
and cloned into EGFP-N2 vector (Clontech). An MT1-
MMP-RFP construct was also constructed using the
pTagRFP-N expression vector (Axxora, San Diego, CA).
Human TIMP-1 and TIMP-3 were ampliﬁed from human
placental cDNA (Clontech) and inserted into the pIEX-5
vector (Novagen) to generate C-terminal S- and His-tags.
Full length MT1-MMP (Full) and a cytoplasmic tail dele-
tion mutant (DCT) were also cloned into pIEX-5. Inserts
containing a C-terminal S-tag were cloned into pENTR4
vector and recombined into the pLenti6/V5 Dest vector
(Invitrogen) according to manufacturer’s instructions. All
constructs were conﬁrmed by sequence analysis and
expression in 293FT cells.
Endothelial cell invasion assay
Assays to study endothelial invasion responses were
established and quantiﬁed as previously described [32, 33].
Collagen matrices were prepared containing 1 lM S1P
(Avanti Polar Lipids). After thorough mixing, collagen was
added at 28 ll per well in 4.5 mm diameter 96-well plates
(Costar). The collagen was allowed to equilibrate for
30 min at 37Ci naC O 2 incubator before adding cells
(40,000 per well) resuspended in 100 ll of medium con-
taining reduced serum II (RSII), recombinant human
VEGF and bFGF and ascorbic acid. Cells were allowed to
invade for 24 h. Culture medium was removed and colla-
gen matrices containing invading ECs were ﬁxed in 3%
glutaraldehyde in PBS overnight. Matrices were stained
with 0.1% toluidine blue in 30% methanol for 10 min prior
to destaining with water.
Transient transfection on coverslips
One microgram of endotoxin-free plasmid DNA in 50 llo f
Opti-MEM (OMEM, Invitrogen) was mixed with 3 llo f
Lipofectamine 2000 (Invitrogen) in 50 ll OMEM, incu-
bated for 20 min at room temperature and then added to
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123400 ll of culture medium containing 10
5 ECs. Mixtures
were added to 12 mm circular cover slips pre-coated with
20 lg/ml collagen type I and allowed to attach for 1 h.
Cells were rinsed with M199 and maintained overnight in
antibiotic-free growth media. Expression of EGFP fusion
proteins was checked by ﬂuorescence microscopy and
conﬁrmed by Western blot analysis.
Quantifying invasion responses
Invasion densities were quantiﬁed by counting ﬁxed cul-
tures under transmitted light using an Olympus CK2
inverted microscope equipped with eyepieces with a
10 9 10 ocular grid. For each condition, four random ﬁelds
were selected and the number of invading cells per high
power ﬁeld (HPF) was counted manually at 209 magniﬁ-
cation (approximately 0.25 mm
2). Data are reported as
mean numbers of invading cells per HPF (±SD). Invasion
length and lumen diameter were measured using digital
images taken from a side view of cultures at 49 magniﬁ-
cation. For each condition, cells (n = 100) were measured
and average invasion distance in micrometers is presented
(±SD).
Calpain activity assay
HUVEC were plated at 50–80% conﬂuence in a 96 well
plate and incubated with M199 medium containing RSII
for 8 h. The cells were pre-treated with calpain inhibitors
or DMSO for 1 h and then loaded with 30 lM of the cal-
pain substrate tBoc-LM-CMAC (Invitrogen). The cells
were treated with or without S1P, GF or S1P ? GF for
30 min, and imaged using a Nikon TE-2000 ﬂuorescent
microscope (excitation 329 nm, emission 409 nm). Fluo-
rescence intensity was measured using Image J software. A
second calpain activity assay was performed using Cal-
pain-Glo
TM Protease Assay Kit (Promega). Cells from 3D
collagen matrices were collected in lysis buffer (0.9%
Triton X-100, 100 lmol/l PMSF and 20 lg/ml aprotinin in
PBS). Freshly prepared Calpain-Glo
TM Reagent was mixed
with samples (1:1) and added to each well of a white
96-well plate containing 40 ll of blank or test sample and
incubated at room temperature for 15 min before analyzing
on a LumiCount luminometer. Experiments were per-
formed three times in triplicate wells. One well represents
six individual collagen matrices from 3D invading cultures.
MT1-MMP activity assay
MT1-MMP activity assays were performed using Senso-
Lyte
TM 520 MMP-14 Assay Kit (Anaspec). Endothelial
cells were transduced with lentiviruses expressing GFP,
TIMP-1, and TIMP-3 and placed on 3D collagen matrices
(six matrices per treatment per time point). Samples were
collected at 6 h of invasion, lysed at 4C for 10 min, and
centrifugedfor10 minat2,5009gat4C.Supernatantswere
collected and stored at -80C until use. Working solutions
were prepared as directed with MT1-MMP substrate. Test
reactions along with positive and negative controls (40 ll)
were combined with the substrate solution. Fluorescence
intensity at Ex/Em = 490/520 nm was read and continu-
ously recorded every 5 min for 60 min. Experiments were
performed three times in triplicate wells. Average values
were recorded and plotted with standard deviation.
Generation and transduction of TIMP-1 and TIMP-3
lentivirus
Lentiviruses were generated as described [33]. Seventy-
two hours after viral transduction, cells were given fresh
growth media and 2 lg/ml blasticidin for 14 days. Con-
ﬂuent cultures were tested in 3D invasion assays [33].
Successful expression of recombinant proteins was con-
ﬁrmed by Western blot analysis using S-protein-HRP
conjugate (Novagen) or antisera speciﬁc to proteins of
interest.
Immunoﬂuorescence
Coverslips were ﬁxed in freshly prepared 4% paraformal-
dehyde in PBS for 10 min. Each was rinsed three times in
Tris/Glycine buffer (0.3% Tris, 1.5% Glycine) and per-
meabilized with 0.5% Triton X-100 in PBS for 30 min with
gentle agitation. Samples were blocked in buffer containing
0.5% TX-100, 1% BSA, and 1% serum overnight at 4C.
Primary antibodies were added in blocking buffer (1:100)
for 2 h at room temperature. After three washes (5 min
each) in 0.1% TX-100 in PBS, Alexa-488- or -594-conju-
gated secondary antibodies (Molecular Probes) were added
(1:200) in blocking buffer for 1 h. After washing, samples
were mounted and imaged using a Nikon TE-2000 ﬂuo-
rescent microscope equipped with appropriate ﬁlters.
Immunoﬂuorescence analyses
To quantify MT1-MMP-GFP localization at the cell
periphery, outlined section of cells were manually traced in
Adobe Photoshop and the pixel intensity inside a 10-pixel-
wide outline of the cell was quantiﬁed in Image J. To avoid
measuring ﬂuorescent intensity from perinuclear staining,
any perinuclear staining that entered the outline was
excluded from the analysis. A cell ﬂuorescence intensity
histogram was normalized by setting the darkest cyto-
plasmic region in the cell to a pixel intensity of zero. The
extent of MT1-MMP-GFP localization to the cell periphery
was deﬁned as the average pixel intensity within the
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123analysis region. The quantiﬁcation of MT1-MMP-GFP
localization to the cell periphery was obtained from three
individual experiments (n = 25 cells).
Immunoprecipitations
Subconﬂuent ECs (1 9 10
6) were harvested and washed
twice with 10 ml of ice-cold PBS. Cell pellets were lysed
in 1 ml of cold lysis buffer [50 mmol/l Tris–HCl, pH 7.5,
150 mmol/l NaCl, 1% NP40, 0.5% Sodium Deoxycholate,
1 mmol/l PMSF, and 19 protease inhibitor cocktail
(Roche)] and incubated for 20 min on ice with occasional
mixing. Cell lysates were centrifuged at 14,000 rpm for
15 min at 4C and supernatants were collected and incu-
bated with protein G-agarose (Pierce) at 4C with agitation
for 1 h before supernatants were incubated with 2 lg/ml of
antisera directed to vimentin (V9, Santa Cruz Biotechnol-
ogy) or MT1-MMP (ab38971, Abcam) for 18 h at 4C with
agitation. Protein G-agarose was added for 2 h at 4C.
Pellets were washed ﬁve times with 1 ml lysis buffer
without protease inhibitors and analyzed by Western blot-
ting. For 3D immunoprecipitations, HUVECs (40,000/
well) were seeded on collagen matrices in 96 well plates
and allowed to invade for 3 h. Cells were washed with ice-
cold PBS and extracted in ice-cold lysis buffer (40 gels/
group).
Generation of stable knockdown cell lines using
shRNA
Lentiviral vectors speciﬁc for calpain 1 (#SHCLNG-
NM005186), calpain 2 (#SHCLNG-NM001748) and
vimentin (#SHCLNG-NM3380) shRNA were purchased
from Sigma-Aldrich. Lentiviral particles were generated by
combining 1.5 lg of backbone shRNA lentiviral plasmid
with 4.5 lg of VIRAPOWER packaging mix (Invitrogen)
into 293FT cells, using Lipofectamine 2000
TM transfection
reagent (Invitrogen) in T25 ﬂasks. Viral supernatants were
harvested at 72 h, centrifuged at 3009g for 5 min, ﬁltered
through a 0.45 lm ﬁlter (Millipore) and incubated with
0.4 9 10
6 HUVEC (passage 2–3) and polybrene (12 lg/
ml). Four hours after viral transduction, cells were given
fresh growth media. Stable transfectants were selected in
the presence of 0.2 lg/ml puromycin for 2 weeks prior to
testing in invasion assays.
Cell surface biotinylation
Cell surface biotinylation was conducted as described by
Stack et al. [34]. Cells were grown to conﬂuence in 6-well
plates, washed twice with 2 ml ice-cold PBS containing
2m MC a
2? and 1 mM Mg
2?, and incubated at 4C with
gentle shaking for 30 min with 0.5 mg/mlcell-impermeable
EZ-Link sulfo-NHS-LC-LC-biotin [sulfosuccinimidyl-60-
(biotinamido)-6-hexanamido hexanoate] (Pierce) in 1 ml
ice-cold PBS, followed by washing twice with ice-cold PBS
and once with 100 mmol/l glycine to quench free biotin.
Cells were detached by scraping, lysed in lysis buffer
(50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% sodium deoxy-
cholate, 1% NP40) with proteinase inhibitors (Roche), and
clariﬁed by centrifugation. To isolate biotinylated cell sur-
face proteins, equal amounts of protein from each sample
were incubated with streptavidin beads at 4C for 14 h,
followed by three washes with 0.5 ml lysis buffer before
centrifugation. After boiling in sample buffer to dissociate
streptavidin bead-biotin complexes, the biotin-labeled
samples were analyzed by 9% SDS-PAGE and immuno-
blotted for MT1-MMP, vimentin, and GAPDH.
Isolation of soluble vimentin fractions
ECs seeded on 3D collagen matrices were allowed to
invade for 6 h. Six collagen matrices per treatment were
washed with cold PBS containing cations. 40 ll of ice-cold
solubilization buffer (1% NP40, 0.5% sodium deoxycho-
late, 19 protease inhibitor cocktail (Roche), and 19 HALT
protease inhibitor) was added to each well. Plates were
placed on ice for 20 min and rotated at 50 rpm. Superna-
tants from each well were collected, pooled, and spun at
12,0009g for 10 min at 4C. Cleared supernatants (200 ll)
were combined with 100 llo f3 9 sample buffer and boiled
for 5 min before analysis using Western blot.
Preparation of membrane fractions from 3D collagen
matrices
Invading EC cultures were established without and with
S1P ? GF for 3 h. Sixty collagen matrices were collected
in 5 ml homogenization buffer [20 mM HEPES (pH 7.4),
1 mM EDTA, 250 mM sucrose, 20 mM NaCl, 1.5 mM
MgCl2, Protease inhibitor cocktail (Roche), phenylmeth-
ylsulfonyl ﬂuoride (2 mM), 1 mmol/l Mercaptoethanol,
0.1 mg/ml collagenase] and digested at 4C. Cells were
disrupted by 10 strokes through a 27 gauge needle and
homogenates were centrifuged at 6,3009g for 5 min to
remove unbroken cells. The supernatant was centrifuged at
150,0009g for 30 min. Pellets were reconstituted in 300 ll
Laemmli sample buffer and boiled for 5 min.
Results
Vimentin is required for endothelial cell invasion
To investigate the role of intermediate ﬁlament proteins in
angiogenic sprouting, we ﬁrst tested whether vimentin was
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123required for S1P- and GF-induced endothelial cell invasion
in 3D collagen matrices. Four individual shRNA sequences
directed to vimentin (shVim 1-4) were introduced using
lentiviral transduction and compared to b2 microglobulin
(shb2M) shRNA as a negative control. Knockdown of
vimentin signiﬁcantly interfered with endothelial cell
invasion responses to SIP and GF (Fig. 1a), and invasion
directly correlated with vimentin expression levels
(Fig. 1b). We also observed cleavage fragments of
vimentin (indicated by open arrowheads, Fig. 1b). Photo-
graphs of invading cultures in control (shb2M) and
shVim1-expressing cells are shown in Fig. 1c. The results
demonstrate vimentin is required for and cleaved during
primary human endothelial cell invasion of collagen
matrices stimulated by S1P and GF.
Vimentin cleavage is calpain-dependent, and GF
predominantly activate calpains
Calpains are intracellular cysteine proteases that can cleave
vimentin [18, 19]. To determine whether vimentin cleavage
during endothelial cell invasion was mediated by calpains,
lysates were prepared from invading cultures treated with a
speciﬁc pharmacological calpain antagonist, calpain inhibi-
tor-III(CI),whichtargetstheactivesitethiolincalpains[35].
Inhibition of calpains using CI dose-dependently blocked
vimentincleavageduringinvasion(Fig. 2a).Thesedatashow
that calpain-dependent vimentin cleavage occurs during
endothelial cell invasion. In the 3D endothelial sprouting
system, S1P combines with GF to stimulate invasion
(SupplementalFigure 1).Becausecalpainscleavedvimentin
duringsproutingresponses,wehypothesizedthatS1PandGF
would activate calpains. To measure calpain activation,
endothelialcellmonolayerswereloadedwith30 lMCMAC,
t-BOC-Leu-Met, a reliable indicator of calpain activation in
live cells [36]. Cells were treated with nothing (CON), S1P,
GF,andS1P ? GF.Aseparategroupwaspre-treatedwithCI
beforetheadditionofS1PandGF(S1P ? GF ? CI).Images
were collected 30 min after treatment (Fig. 2b) and reveal
that S1P increased calpain activation relative to control, but
GF and S1P ? GF were more effective at increasing calpain
activationcomparedtoCON,orS1P.Signalintensityincells
treated with S1P ? GF ? CI was signiﬁcantly decreased
compared to control, indicating CI treatment signiﬁcantly
reducedcalpainactivation.Althoughsimilarexperimentsfor
quantifyingcalpainactivitywereconductedwith3Dcultures,
this method was not compatible with polymerized collagen
matrices (data not shown). To test whether SIP or GF
activated calpain in 3D cultures, an alternative approach was
used with 6 h invading ECs that utilized a luminometric
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Fig. 1 Vimentin knockdown interfered with invasion responses.
a Quantiﬁcation of invasion density resulting from shRNA-mediated
knockdown of beta 2 microglobulin (shb2M) or vimentin (shVim).
Four independent sequences are shown for vimentin knockdown
(shVim1-4). Cells expressing indicated shRNA sequences were
allowed to invade in the presence of S1P, VEGF, and bFGF, as
previously described [32]. Cultures were ﬁxed at 16 h of invasion and
a representative experiment (n = 4) is shown. Data presented are
average values from ﬁve 1 mm
2 ﬁelds (±SD). ***P\0.001,
**P\0.01 versus shb2M, Student’s t test. b Western blot analyses
of whole cell lysates of invading cells (16 h) using vimentin-, beta 2
microglobulin (b2M)-, and tubulin-speciﬁc antisera. Open arrow-
heads indicate vimentin cleavage products. c Representative photo-
graphs from a side view illustrate invasion responses observed with
control and vimentin knockdown cells. Scale bar, 100 lm
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123substrate that selectively detected activated calpains. S1P
increasedcalpainactivitycomparedtocontrol(Supplemental
Figure 2A). Calpain activity was further enhanced by GF,
and combining S1P ? GF resulted in maximal calpain acti-
vation. Also, CI blocked calpain activation (Supplemental
Figure 2B),demonstratingefﬁcacyofthiscompoundagainst
calpains. These results suggest that GF are more effective
than S1P at increasing calpain activation in ECs. To test
whethervimentincleavageoccursinresponsetoS1PorGFin
invading ECs, whole cell extracts were collected after 6 h of
invasion.At4 h,GFappeartoinduceslightlymore vimentin
cleavagethanS1P(Fig. 2c),andthisismoreobviousat6 hof
invasion, which is when sprout initiation begins [33]. Data
were quantiﬁed in Fig. 2d and reveal GF are signiﬁcantly
more effective at inducing vimentin cleavage in ECs seeded
on 3D collagen matrices than S1P, agreeing with results in
Fig. 2b and Supplemental Figure 2.
Calpain activation partially regulates endothelial cell
invasion
To test for a functional role for calpains in endothelial cell
invasionresponses,cellsweretreatedwithCI.Quantiﬁcation
ofinvasionresponsesrevealedadose-dependentinhibitionof
invasion by CI (Fig. 3a), associating calpain activation,
vimentin cleavage and invasion. No adverse effects on cell
monolayers or evidence of compromised cell viability were
observedwithcalpaininhibition,andvehiclehadnoeffecton
invasion (data not shown). Sprout morphology of invading
cells wassigniﬁcantlyalteredinthepresenceofCI(Fig. 3b).
Representative side views of invading structures (Fig. 3b)
shows control cultures are multicellular and contain lumens
(indicated by black arrows), while those treated with CI
exhibited thin sprouts and failed to form multicellular struc-
tures surrounding a lumen (Fig. 3b, white arrows). We
observed a marked decrease in sprout length, reported as
invasion distance (Fig. 3c) and nearly complete blockade
of lumen formation (Fig. 3d). These ﬁndings support that
calpains are required for endothelial cell invasion responses.
To conﬁrm pharmacological studies, recombinant len-
tiviruses delivering short hairpin RNA (shRNA) were gen-
erated to silence beta 2 microglobulin (shb2M), calpain 1
(shCalp1) and calpain 2 (shCalp2). A side view of invasion
responses is shown in Fig. 4a. Cell lines stably expressing
shRNAs exhibited no changes in morphology compared to
wild-type (CON) cells in culture. Quantiﬁcation of invading
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Fig. 2 Calpains are activated by growth factors and result in
vimentin cleavage. a Invading cultures were treated with indicated
doses of CI and allowed to invade collagen matrices for 22 h in the
presence of S1P and GF. Whole cell extracts were subjected to
Western blotting and probed with antisera directed to vimentin. Blots
were stripped and re-probed with GAPDH- speciﬁc antisera. Results
are representative of three independent experiments. b ECs were
plated at 80% conﬂuence in a 96 well plate in M199 medium
containing RSII for 8 h. The cells were pre-treated with 31.6 lMC I
or DMSO (CON) for 1 h and then loaded with 30 lM of the calpain
substrate tBoc-LM-CMAC. Cells were treated without (CON) or with
S1P (1 lM), GF (40 ng/ml VEGF and bFGF) or S1P ? GF for
30 min and imaged. Calpain activity was quantiﬁed as indicated in
the ‘‘Materials and methods’’ section. Results are representative of
four independent experiments. Data shown are average values ± SD.
*P\0.05, and **P\0.01 compared to Control, ***P\0.001
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tion of intensities of vimentin cleavage products with treatment
conditions. Data are derived by averaging band intensities from three
independent experiments. **P\0.01 versus CON;
P\0.05 versus
all other treatments by Student’s t test
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123cell density revealed that shb2M-expressing cells invaded
comparably to non-transduced cells, and calpain 1 silencing
had no effect (Fig. 4b). In contrast, silencing of calpain 2
signiﬁcantly reduced the number of invading cells (Fig. 4b)
and the length of invading structures (Fig. 4c). Western blot
analyses conﬁrmed successful knockdown of calpains 1 and
2 (Fig. 4d), but also revealed a reproducible upregulation of
calpain 2 with calpain 1 knockdown, suggesting calpain 2
may be compensating. To rule out non-speciﬁc effects of
calpain2shRNA,multiplesequencesweretested.Compared
to ECs expressing shb2M, shCalp2-2, shCalp2-3 and
shCalp2-4 silencing signiﬁcantly decreased invasion
responses (Supplemental Figure 3A). Western blot analyses
of lysates from invading cultures revealed successful
silencing of b2M and calpain 2 expression in invading cul-
tures (Supplemental Figure 3B). Invasion distance was
partially reduced in shCalp2 treatment (Supplemental Fig-
ure 3C). Photographs of cultures (Supplemental Figure 3D)
revealed a thin sprout morphology with calpain 2 silencing
(arrows). These data indicate calpain silencing decreased
sprouting responses and are consistent with results with
pharmacological calpain inhibition shown in Fig. 3.
MT1-MMP activation is not extensively altered
by pro-angiogenic factors
Thus far, our data demonstrate that calpain inhibition
decreasedsproutdensity,lumenformationandsproutlength,
and overall limited the ability of ECs to invade collagen
matrices. MT1-MMP is a transmembrane metalloproteinase
that cleaves extracellular matrix proteins and mediates
sprouting events and lumen formation during endothelial
morphogenesis in 3D matrices [26–31]. To test whether
calpain and vimentin activate MT1-MMP, MT1-MMP
activation assays were performed [34]. Extracts isolated
from invading cultures were combined with a ﬂuorogenic
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Fig. 3 Endothelial cell invasion stimulated by S1P and GF requires
calpain activation. a Invasion experiments were established by pre-
incubating cells with CI at the concentrations indicated for 30 min
prior to seeding on collagen matrices. Cells were allowed to invade
for 22 h. Data represent average numbers of invading cells per
standardized ﬁeld ± SD (n = 4). b Representative photographs of a
side view of invading cells from control (CON) and 100 lMC I
treatment. Arrowhead indicates original monolayer. Black arrows
indicate a lumen and white arrows indicate altered structures
observed with CI treatment. c Quantiﬁcation of average invasion
distances (in microns) from monolayer to the tip of invading
structures control (CON) and CI treated group (n = 100 cells).
d Quantiﬁcation of lumen diameter (in microns) of invading
structures in control (CON) and 100 lM CI treated group (n = 100
cells). Results are representative of three independent experiments.
Data shown in a, c, and d are average values ± SD. *P\0.05,
**P\0.01 versus control by Student’s t test
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123peptide sensitive to MT1-MMP cleavage. Because this
substrate is also sensitive to cleavage by MMP-1, MMP-2,
MMP-7, MMP-8, MMP-12 and MMP-13, various inhibitors
were included to rule out a contribution of soluble MMPs to
the overall signal. Cells were transduced with lentiviruses
expressing GFP control, TIMP-1, and TIMP-3 and allowed
to invade collagen matrices with no stimulation (CON),
S1P (1 lM), GF (40 ng/ml each VEGF and bFGF)
and S1P ? GF (Fig. 5a). TIMP-1 expression decreased
substratecleavagecomparedtoGFP-expressingcells,dueto
inhibitionofsolubleMMPs.Acompleteblockadeofactivity
was seen with TIMP-3 expression, ﬁtting with inhibition of
all MMPs. The data in the TIMP-1 group are indicative of
membrane-associated MMP activity, because TIMP-1 neu-
tralizes soluble MMPs [37]. Importantly, invasion is unaf-
fectedbyTIMP-1[38].Comparedtocontrol(CON),S1Pand
GF slightly increased MT1-MMP activation (Fig. 5A,
TIMP-1 treatment). Combined S1P and GF treatment
resulted in maximal MT1-MMP activation. In the presence
of TIMP-1, MT1-MMP activation was slightly, but signiﬁ-
cantly, decreased by pretreatment with CI (Fig. 5b), calpain
2 silencing (Fig. 5c), and vimentin knockdown (Fig. 5d).
Thus, silencing of calpain and vimentin only modestly
decreased MT1-MMP activation.
S1P stimulated calpain-dependent membrane
translocation of MT1-MMP
MT1-MMP is required for endothelial cell invasion [27, 28,
30]. Because calpain inhibition and vimentin silencing sig-
niﬁcantly decreased invasion responses (Figs. 1, 3) but only
marginally reduced MT1-MMP activation (Fig. 5b–d), an
alternative mechanism is likely responsible for controlling
invasion.Beliveauetal.reportedS1PstimulatedMT1-MMP
membrane translocation [39], and our data show MT1-
MMP-GFP translocated to the cell membrane in response to
S1P stimulation (Supplemental Figure 4A, white arrow-
head), but not following GF stimulation. Data were con-
ﬁrmed in wild type HUVEC using MT1-MMP antibodies
(Supplemental Figure 4B) and show that S1P stimulated
membrane translocation of endogenous MT1-MMP in ECs.
We next tested whether calpain inhibition altered mem-
brane translocation of MT1-MMP. Pretreating cells with CI
decreased MT1-MMP-GFP membrane translocation in
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Fig. 4 Calpain knockdown signiﬁcantly reduced EC invasion. ECs
were not treated (CON) or transduced with lentiviruses delivering
shRNA directed to beta 2 microglobulin (shb2M; negative control),
calpain 1 (shCalp1) and calpain 2 (shCalp2). Stable cell lines were
selected with puromycin (0.2 lg/ml) for 2 weeks prior to testing in
invasion assays. a Representative photographs of a side view of
invading cells from each treatment group. Bar = 100 lm. b Quanti-
ﬁcation of the average number of invading cells per 0.25 mm
2 ﬁeld
(n = 4 ﬁelds) from a representative experiment (n = 4); **P\0.01
versus control, Student’s t test. c Quantiﬁcation of the average
invasion distances (in lm) recorded from monolayer to leading edge
of invading structures (n = 100 cells). Data shown are average
values ± SD. *P\0.05 versus control, Student’s t test. d Western
blot analyses of whole cell lysates from invading cultures (24 h)
probed with calpain 1- (Calp 1), calpain 2- (Calp 2) and GAPDH-
speciﬁc antisera
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123response to S1P (Fig. 6a), supporting that calpains are
required for MT1-MMP-GFP membrane translocation.
These results were conﬁrmed in ECs expressing shCalp2-2
(data not shown). Vimentin knockdown also blocked MT1-
MMP translocation to the membrane (Fig. 6b). MT1-MMP
fused to green ﬂuorescent protein (MT1-MMP-GFP)
translocated to the membrane following S1P stimulation in
non-transfected endothelial cells (HUVEC) and ECs
expressing shb2M (white arrowheads), but no membrane
localization of MT1-MMP-GFP was seen in vimentin
knockdown cells (shVim1). Quantiﬁcation of MT1-MMP
membrane localization showed a signiﬁcant reduction with
shVim1 expression (Fig. 6c). These data were conﬁrmed in
cells transiently transfected with vectors encoding MT1-
MMP fused to a C-terminal red ﬂuorescent protein (Sup-
plemental Figure 5). These data show that calpain activa-
tion and vimentin expression are required for successful
S1P-induced membrane translocation of MT1-MMP, and to
a lesser extent, MT1-MMP activation.
To provide biochemical evidence for MT1-MMP
membrane localization, membrane fractions were isolated
from 3D cultures (Fig. 7a). Compared to no treatment
(CON), S1P ? GF stimulation enhanced MT1-MMP levels
in isolated membrane fractions. Probing with Pan-cadherin
antisera revealed an increase in cadherin membrane
translocation, consistent with a previous report that S1P
strengthens adherens junction formation [40]. Interestingly,
higher levels of full length vimentin (black arrowhead) and
lower molecular weight vimentin fragments (white arrow-
heads) were also detectable in cultures treated with
S1P ? GF compared to CON. The av and b3 integrin
subunits levels were similar in both treatment groups and
served as loading controls. In Supplemental Figure 6,
fractions were probed for known cytosolic and membrane
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Fig. 5 Calpain inhibition and vimentin silencing modestly inhibit
MT1-MMP activation. a Optimization of conditions to quantify MT1-
MMP activation. Stable endothelial cell lines expressing GFP, TIMP-
1 and TIMP-3 were generated using recombinant lentiviruses and
were allowed to invade for 6 h in the presence of no treatment (CON),
1 lM S1P (S1P), 40 ng/ml VEGF and bFGF (GF) or S1P ? GF.
Lysates were analyzed using MT1-MMP ﬂuorescence activation
assays (see ‘‘Materials and methods’’ section). b Quantiﬁcation of
MT1-MMP activity in cultures established using TIMP-1 conditioned
medium. Invading cultures (6 h) were treated with vehicle (CON) or
CI (100 lM). Lysates from 3D invading cultures (6 h) were prepared
c from ECs expressing no shRNA (CON) or shRNA directed b2M
(shb2M), calpain 1 (shCalp1) and calpain 2 (shCalp2) and d shb2M
and shVim1. Lysates were combined with TIMP-1 conditioned
medium and quantiﬁed in MT1-MMP activation assays as shown in
a. All data were expressed as relative MT1-MMP activity and were
obtained by performing three replicates per treatment with six
collagen matrices collected for each replicate. Data in all panels
represent average values ± SD. *P\0.05, **P\0.01 versus con-
trol by Student’s t test
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123proteins to conﬁrm successful isolation of membrane
fractions.
These membrane fractionation studies were reinforced
by cell surface biotinylation assays (Fig. 7b). Because S1P
predominantly enhanced MT1-MMP membrane transloca-
tion (Supplemental Figure 4), these studies were performed
with S1P alone. Increased MT1-MMP membrane translo-
cation was observed 15 min after S1P treatment and
remained elevated for 1 h (Fig. 7b). Like MT1-MMP,
vimentin association with biotinylated surface proteins,
increased 15 min after S1P treatment and decreased
somewhat at 30 and 60 min (Fig. 7b). We observed this to
be full-length vimentin (60 kDa). Calpain 2 silencing
decreased MT1-MMP surface biotinylation following S1P
treatment (Fig. 7c), compared to shb2M silencing, where
S1P treatment for 15 and 30 min induced MT1-MMP
surface biotinylation. Cells expressing shCalp2 lacked
induction of surface labeled MT1-MMP, and interestingly,
baseline levels at time zero were reduced, as well (Fig. 7c).
Identical experiments were conducted with ECs expressing
shVim1, where vimentin knockdown was observed with
shVim1 expression compared to shb2M control (Fig. 7d).
Like shCalp2 treatment, we observed decreased amounts of
surface biotinylated MT1-MMP after S1P stimulation in
cells expressing shVim compared to shb2M controls.
These data reinforce that calpain activation and vimentin
are required for successful surface translocation of MT1-
MMP, which mediates extracellular matrix proteolysis
during endothelial sprouting events.
S1P stimulated vimentin localization to the plasma
membrane
We next tested whether S1P and GF altered vimentin
localization. Vimentin localization was enhanced at the
wounded edge of an endothelial monolayer following
stimulation with S1P (white arrowheads, Fig. 8), while no
localization of vimentin at the membrane was seen in CON
or GF treatment. Treatment with S1P ? GF appeared
similar to S1P alone. CI treatment signiﬁcantly reduced
vimentin localization to the membrane in response to
S1P ? GF (S1P ? GF ? CI). These data show that like
MT1-MMP translocation to the plasma membrane,
vimentin membrane translocation was stimulated by S1P.
This is a signiﬁcant departure from the normal distribution
of vimentin which is arranged in polymerized ﬁlaments in
resting cells.
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Fig. 6 S1P stimulated membrane translocation of MT1-MMP is
calpain- and vimentin-dependent. a Calpain inhibition blocked S1P-
stimulated MT1-MMP membrane translocation. ECs were transfected
with MT1-MMP-GFP and seeded overnight on cover slips. Cells were
pretreated with vehicle (S1P) or 100 lM CI for 30 min prior to
adding S1P for 1 h. Cells were ﬁxed in paraformaldehyde, counter-
stained with DAPI, mounted and imaged. Arrowheads indicate MT1-
MMP-GFP localization to the membrane. b Silencing vimentin
decreased MT1-MMP membrane translocation. ECs expressing
shb2M (CON) or shVim1 were transiently transfected with MT1-
MMP-GFP, seeded on coverslips overnight and treated with 1 lM
S1P for 1 h. Following paraformaldehyde ﬁxation, cells were
additionally counterstained for vimentin (red). Arrowheads indicate
MT1-MMP-GFP localization to the membrane. Bar = 50 lm.
c Quantiﬁcation of images shown in b. Twenty-ﬁve cells in each
group were analyzed as described in the ‘‘Materials and methods’’
section. **P\0.01 versus shVim1 by Student’s t test
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123Vimentin complexed with MT1-MMP
Our data from biochemical and immunoﬂuorescence
studies indicated that, like MT1-MMP, vimentin localized
to the plasma membrane in response to S1P. To test whe-
ther vimentin complexed with MT1-MMP, immunopre-
cipitations were performed with lysates from 3D invasion
cultures. Endothelial cells were seeded on collagen matri-
ces in the absence (CON) or presence of S1P ? GF prior to
performing immunoprecipitations with MT1-MMP and
vimentin antisera. Increased amounts of vimentin immu-
noprecipitated with MT1-MMP antisera following
S1P ? GF stimulation (Fig. 9a). MT1-MMP also immu-
noprecipitated with vimentin antisera (Fig. 9b), although
no increase was seen with S1P ? GF treatment, possibly
because vimentin is an abundant protein and likely only a
fraction of total vimentin is captured in reactions. No
association between MT1-MMP or vimentin were observed
with IgG controls. Thus, a complex containing MT1-MMP
and vimentin formed in 3D endothelial cultures.
To test whether vimentin bound to the cytoplasmic tail
of MT1-MMP, immunoprecipitations were performed with
full length (Full) and cytoplasmic tail deletions (DCT) of
MT1-MMP that expressed a cytoplasmic S-tag (Fig. 9c).
Full length, but not DCT, MT1-MMP constructs associated
with vimentin, and no complex formation was seen with
IgG control antibodies, indicating that vimentin associated
with the cytoplasmic tail of MT1-MMP.
To determine if calpain inhibition interfered with for-
mation of vimentin-MT1-MMP complexes, lysates were
prepared from 3D invading cultures and immunoprecipi-
tated with MT1-MMP-speciﬁc antisera. Equal amounts of
MT1-MMP were detectable in immunoprecipitates and
present in starting material (Fig. 9d). However, in the
presence of CI, vimentin did not associate with MT1-MMP
(Fig. 9d). Interestingly, probing for detectable amounts of
vimentin in the starting material revealed a signiﬁcant
decrease with CI. These data support that calpain cleavage
liberated detergent soluble vimentin (which was detectable
in the starting material used for immunoprecipitations) and
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Fig. 7 Pro-angiogenic factor-stimulated MT1-MMP membrane
translocation is dependent on calpain activation and vimentin.
a Isolated membrane fractions of 3D cultures were prepared using
ultracentrifugation. ECs were allowed to invade in the presence of
S1P ? GF or nothing (CON) for 3 h. Samples were probed for MT1-
MMP, Pan-Cadherin (Pan-Cad), vimentin, and av and b3 integrin
subunits using Western blot analyses. b S1P increased MT1-MMP
membrane translocation. Cell surface biotinylation assays [34] were
utilized for ECs treated with 1 lM S1P for 0, 15, 30 and 60 min.
Extracts were incubated with avidin-Sepharose, and eluates were
immunoblotted and probed with antisera speciﬁc to MT1-MMP and
vimentin. Starting material was probed with GAPDH-speciﬁc anti-
sera. c, d Cell surface biotinylation assays were conducted as in
b with ECs expressing shb2M and shCalp2 (c) and shb2M and
shVim1 (d). Cells were treated with S1P for 0, 15 and 30 min and
surface labeled. Eluates were probed with antisera directed to MT1-
MMP and starting material was probed with antibodies directed to
GAPDH, calpain 2 (c) and vimentin (d)
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123this intracellular pool of soluble vimentin complexed with
MT1-MMP.
Calpain cleaves the N-terminus of vimentin [18]. An
intact N-terminal rod of vimentin is required to form poly-
merizedintermediateﬁlaments[20],andvimentinfragments
generatedfollowingcalpaincleavagefailtopolymerize[41].
Polymerizedintermediateﬁlamentsareresistanttodetergent
solubilization. Based on these properties of vimentin, we
tested whether pro-angiogenic factors altered the state of
vimentin polymerization by extracting with a detergent
solution. Supernatants of 6 h invading cells were collected
after detergent solubilization and analyzed by Western
blotting.Comparedtonotreatment(CON),solublevimentin
levels were enhanced slightly with S1P treatment, but more
effectively enhanced with GF treatment (Fig. 10a). Com-
biningS1P ? GFtreatmentwasnotsigniﬁcantlyhigherthan
GF alone, suggesting GF treatment predominantly stimu-
lated vimentin cleavage. Data were quantiﬁed in Fig. 10b.
Thus, GF induced vimentin cleavage and enhanced soluble
vimentin fragments in invading ECs. In separate experi-
ments, pre-treatment of 3D invading cultures with CI
decreaseddetectableamounts ofsolublevimentincompared
to treatment with S1P ? GF alone (Fig. 10c). Fitting with
this observation, immunoﬂuorescence staining indicated
more intact (or detergent insoluble) vimentin was present
with calpain inhibition (Fig. 10d). In agreement with these
results, calpain 2 silencing decreased vimentin cleavage in
whole cell lysates and detergent lysates (Supplemental
Figures 7A and 7B, respectively).
Overall, these data show that GFs predominantly activate
calpains, which (presumably through cleavage) stimulate
vimentin depolymerization and liberation of detergent sol-
uble vimentin. We ﬁnd here for the ﬁrst time that soluble
vimentincomplexedwiththecytoplasmictailofMT1-MMP
and facilitated S1P-induced MT1-MMP membrane translo-
cation, which is required for endothelial cell invasion.
Discussion
We report here a mechanism to control endothelial
sprouting in 3D collagen matrices, which mimics activation
of the angiogenic switch. Calpain activation altered the
polymerization state of vimentin, which complexed with
MT1-MMP to accomplish proper membrane localization of
MT1-MMP, which facilitated collagen degradation to
allow successful sprouting responses, as others have
reported requires MT1-MMP [26–28, 30]. The results
presented here show for the ﬁrst time that calpain-depen-
dent depolymerization of intermediate ﬁlaments directs
successful membrane localization of MT1-MMP and
results in endothelial cell sprouting responses.
Our results are the ﬁrst to demonstrate an endothelial-
speciﬁc requirement for vimentin in controlling angiogenic
50 µm
CON GF
S1P+GF S1P+GF+CI S1P
CI
Fig. 8 Vimentin localization to the cell periphery requires calpain
activation. Cells were seeded on collagen coated coverslips overnight.
Monolayers were wounded, washed twice with M199, and allowed to
recover for 2 h. In CI groups, cells were pretreated for 30 min (1.5 h
post-wounding) prior to S1P ? GF treatment. Cells were treated as
indicated with nothing (CON), 1 lM S1P, GF (40 ng/ml VEGF and
bFGF), S1P ? GF, CI, and S1P ? GF ? CI for 30 min. Immuno-
ﬂuorescence analysis was performed following methanol ﬁxation
using antibodies directed to vimentin. White arrowheads indicate
vimentin localization to the plasma membrane. Note, similar mem-
brane localization was not seen with paraformaldehyde ﬁxation
(Fig. 6B)
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123responses. While there has been some evidence implicating
vimentin in regulating angiogenic and vasculogenic
responses [10, 11, 42], a direct requirement for vimentin in
sprouting ECs has not been reported. Vimentin is an
intermediate ﬁlament (IF) that is involved in many
important physiological functions, such as the distribution
of organelles, signal transduction, cell polarity and gene
regulation [43–45]. To our knowledge, this is the ﬁrst
report that detergent soluble vimentin complexes with
MT1-MMP, and our data are consistent with vimentin
liberation by active calpains. Calpains cleave the N-ter-
minal region, or head of vimentin [18, 19]. The head region
is required for assembly of IF networks [41, 46]. Headless
vimentin cannot polymerize or assemble into ﬁlaments, but
can assemble into monomers, dimers or tetramers [47].
Tetrameric vimentin complexes tend to be homogenous
and increase in the presence of physiological salts and pH
7.5 [48]. Further, headless vimentin can prevent full-length
vimentin from polymerizing, and can partially disrupt
polymerized networks comprised of full-length vimentin
[48]. The soluble vimentin we detect is comprised of full
length (60 kDa) and truncated vimentin (43–50 kDa),
indicating that the soluble vimentin pool generated by
calpain cleavage may be comprised of mixed complexes of
cleaved and soluble vimentin, which do not assemble into
regular IF networks, but may be available for associating
with MT1-MMP to facilitate matrix proteolysis and endo-
thelial sprouting. Although we can only detect full length
vimentin associated with MT1-MMP in immunoprecipita-
tion experiments, this may be the result of experimental
binding conditions and overnight incubations. Thus,
we cannot rule out binding of headless vimentin to
MT1-MMP. One possibility we have not addressed here is
that other signals, such as vimentin phosphorylation, which
also induces depolymerization [49], may be necessary to
completely disrupt polymerized vimentin networks.
We show that calpain activation, vimentin cleavage, and
increased vimentin solubility following GF stimulation
couple with MT1-MMP membrane translocation that is
driven by S1P to facilitate sprouting responses. We
observed that MT1-MMP activation was not controlled by
calpain activation or the presence of vimentin because
vimentin knockdown and calpain inhibition only modestly
blocked MT1 activation, yet signiﬁcantly block invasion.
Thus, localization of MT1-MMP was not direct by cal-
pains. We observed that S1P, but not GF, stimulated
localization of MT1-MMP to the plasma membrane
using multiple approaches. The ability of S1P to stimulate
MT1-MMP surface translocation may explain why S1P
combines with either GF or WSS to stimulate invasion
responses [33, 50]. GF and WSS activate calpains [22, 51],
but our data suggest that global calpain activation is not
sufﬁcient to explain sprouting responses. Neither GF nor
WSS treatment alone stimulated invasion (Supplemental
Figure 1, [50]). Thus, calpain activation, and subsequent
vimentin cleavage are not sufﬁcient for initiating sprouting
responses, but must be combined with proper membrane
localization of MT1-MMP, which is driven by S1P. Thus,
integration of multiple extracellular signals are needed to
activate the angiogenic switch.
We report that vimentin complexed with the cytoplasmic
tail of MT1-MMP. This region of MT1-MMP is involved in
endocytic recycling and activation of MT1-MMP [52]. S1P
stimulated membrane translocation of MT1-MMP that is
dependent on phosphorylation of Tyr
573 [39]. We showed
here that S1P-induced MT1-MMP membrane translocation
required calpain activation and vimentin. In addition, pro-
angiogenic factors increasedthe amount ofsoluble vimentin
available to complex with MT1-MMP. Silencing vimentin
and calpain signiﬁcantly reduced MT1-MMP surface trans-
location in response to S1P. Our data support a model in
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MT1-MMP
MT1-MMP
(starting)
IP: MT1-MMP
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CON       CI
Vimentin (IB)
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IP: MT1-MMP 
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D C
IP: Vimentin
IB: S-protein
MT1-MMP-S 
(starting)
MT1-MMP-S
(eluates)
Fig. 9 Vimentin complexed with MT1-MMP in 3D invading EC
cultures. Experiments in a, b, d were conducted with 3D endothelial
cultures at 6 h of invasion. a Detergent lysates were immunoprecip-
itated with MT1-MMP-speciﬁc or IgG control antisera (IgG).
Samples were probed with antisera directed to vimentin. b Reverse
immunoprecipitations were performed by combining cleared lysates
with vimentin-speciﬁc or IgG control antisera. Eluates were probed
with MT1-MMP-speciﬁc antisera. c HEK293 cells were transfected
with full length (Full) or cytoplasmic deletions (DCT) of MT1-MMP
containing a C-terminal S-tag. Detergent extracts were cleared and
immunoprecipitated with vimentin-speciﬁc antisera. Eluates and
starting material were probed with S-tag-speciﬁc antibodies. An
IgG control was included for cells expressing Full length MT1-MMP
constructs. d Prior to placing endothelial cells on collagen matrices to
initiate invasion, cells were treated with DMSO (CON) or 100 lMC I
for 30 min in solution. Detergent extracts of 6 h invading 3D cultures
were probed with MT1-MMP- and vimentin-speciﬁc antisera. Starting
material was probed with antisera speciﬁc to MT1-MMP, vimentin,
and GAPDH
Angiogenesis (2012) 15:287–303 299
123which pro-angiogenic signals activated calpain, which
cleaved and depolymerized vimentin; This pool of soluble
vimentincomplexedwiththecytoplasmictailofMT1-MMP
and aided MT1-MMP cell surface translocation. Vimentin
fragmentsgeneratedby calpain cleavage have been reported
to complex with and protect Erk1/2 from dephosphorylation
tofacilitateneuronalrepair[53,54],providingsomesupport
forthepossibilitythatcomplexformationbyvimentinmight
regulate MT1-MMP phosphorylation levels. Whether
vimentin availability affects phosphorylation of MT1-MMP
remainstobetested.Inaddition,probingthespeciﬁcbinding
interactions between MT1-MMP and vimentin is warranted.
MT1-MMP has been established as a key mediator of EC
sprouting processes [28, 30]. Because MT1-MMP is teth-
ered to the membrane, it is perfectly suited to mediate
controlled extracellular matrix proteolysis in close prox-
imity to the cell surface [26, 30, 31, 55]. Consequently, the
signals that regulate membrane localization of MT1-MMP
are critical to understand. Calpains have previously been
implicated in controlling angiogenic responses, and we
have found recently calpain is necessary for MT1-MMP
surface translocation in a model of wall shear stress and
S1P-induced invasion [56]. Senger et al. previously
reported that moderate inhibition of calpain led to normal-
ization of neovascularization responses in multiple models
of pathological angiogenesis [25, 57]. One potential
explanation for those data,supported by our ﬁndings here, is
that moderate calpain inhibition also partially limited MT1-
MMP-mediated proteolysis and new blood vessel growth,
allowing slightly less robust and perhaps more controlled
angiogenic responses to occur. This inhibition ultimately
resulted in a more normalized vasculature. Thus, our data
support the conclusions of Senger et al., who showed that
manipulation of calpain activity is a viable strategy for
normalizing pathological angiogenesis [25, 57], as is con-
trolling surface translocation of MT1-MMP.
Here, we demonstrate that vimentin is associated with
the cell membrane in invading ECs, consistent with a
previous report [58]. Our data suggest that vimentin par-
ticipates in assembling a molecular complex with MT1-
MMP to coordinate EC sprout extension and invasion.
Vimentin localization was found to increase in anterior
portions of ECs traversing ﬁlters in Boyden chamber assays
and in the developing retinal vasculature [59]. Further,
caveolin co-puriﬁed with intermediate ﬁlaments in ECs,
and this interaction required Tyr
14 [59]. Interestingly,
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Fig. 10 Pro-angiogenic factors stimulated calpain-dependent libera-
tion of detergent-soluble vimentin. a ECs were allowed to invade for
6 h. Plates were placed on ice, and wells were washed with 200 llo f
cold PBS. Cells were treated with 1% NP-40, 0.05% Na deoxycholate
in Hepes Buffered saline, pH 7.4 (40 ll per well). Cleared superna-
tants were used for Western blot analyses using vimentin-speciﬁc
antisera. b Quantiﬁcation of intensities of vimentin cleavage products
with treatment conditions. Data are derived by averaging band
intensities from three independent experiments. **P\0.01 versus
CON;
P\0.05 versus all other treatments by Student’s t test. c ECs
were allowed to invade for 6 h in the presence of S1P and GF. Cells
were pre-treated with DMSO (S1P ? GF) or 10 lM CI. Samples
were processed as described in a and probed for vimentin using
Western blot analyses. d Following collection of supernatants
analyzed in c, cultures were ﬁxed in paraformaldehyde and probed
for vimentin using immunoﬂuorescence. Red staining indicates
vimentin and blue, DAPI
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123MT1-MMP is enriched in caveolae [60], but MT1-MMP
does not contain a consensus binding site for caveolin.
Thus, our data suggest that vimentin may provide a
molecular link between caveolin and MT1-MMP. Vimen-
tin also complexed with the a2b1 integrin and co-localized
with a2b1 in focal adhesion complexes [61]. Davis et al.
have shown a2b1 is part of a signaling complex that con-
tains MT1-MMP and controls EC tubulogenesis and lumen
formation [62], and the a2b1 integrin mediates EC invasion
in type I collagen matrices [38]. We ﬁnd that vimentin is
present in membrane preparations, which has previously
been reported [58], raising the possibility that vimentin
participates in assembling molecular complexes composed
of caveolin Tyr
14, MT1-MMP, the a2b1 integrin and other
surface molecules to coordinate EC sprout extension and
invasion. It is tempting to speculate that integrin recogni-
tion of collagen, a pro-morphogenic substrate for ECs [63],
initiates assembly of a molecular complex composed of
a2b1, MT1-MMP, and caveolin Tyr
14 at the cell surface
that is stabilized by vimentin to facilitate endothelial
morphogenesis and sprouting events.
In summary, our data deﬁne a pathway downstream of
pro-angiogenic factors for calpain activation, vimentin
cleavage and depolymerization, and MT1-MMP surface
translocation that controls the initiation of endothelial cell
sprout formation. We ﬁnd that calpain and vimentin are
required to regulate proper membrane translocation of
MT1-MMP, explaining the ability of calpain inhibition and
vimentin silencing to block endothelial sprouting events.
Because these molecules are universally expressed (and in
the case of vimentin, upregulated) in malignant disease,
this pathway may also regulate invasive, metastatic cell
behavior. These data for the ﬁrst time demonstrate a
functional link between calpain activation, vimentin
cleavage, vimentin reorganization, and membrane translo-
cation of MT1-MMP in EC sprout initiation.
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